UK Markets closed

OKYO Pharma Limited: Result of Annual General Meeting

·3-min read
OKYO Pharma LTD
OKYO Pharma LTD

LONDON and NEW YORK, Sept. 07, 2022 (GLOBE NEWSWIRE) -- The board of directors of OKYO Pharma Limited (LSE: OKYO; NASDAQ: OKYO), a bio-pharmaceutical company focused on developing an innovative approach to dry eye care and ocular pain, is pleased to announce that at the Annual General Meeting ("AGM") of the Company held earlier today all resolutions were duly passed.

The result of the poll, including the proxy voting, is as follows:

 

 

For

Against

Discretion

Withheld

 

For + Discretion

Resolution

Description

Votes

% Votes
Cast

Votes

% Votes
Cast

Votes

% Votes
Cast

Votes

Total
Votes Cast
(excl.
Votes
Withheld)

Votes

% Votes
Cast

RES:001

REPORT AND ACCOUNTS

560,824,152

99.99852%

325

0.00006%

8,000

0.00143%

3,000

560,832,477

560,832,152

99.99994

%

RES:002

REMUNERATION REPORT

560,789,302

99.99252%

33,975

0.00606%

8,000

0.00143%

4,200

560,831,277

560,797,302

99.99394

%

RES:003

RE-ELECT
MR W SIMON

560,823,652

99.99843%

825

0.00015%

8,000

0.00143%

3,000

560,832,477

560,831,652

99.99985

%

RES:004

RE-ELECT
DR.G S. JACOB

560,823,652

99.99843%

825

0.00015%

8,000

0.00143%

3,000

560,832,477

560,831,652

99.99985

%

RES:005

RE-ELECT MR J BRANCACCIO

560,823,652

99.99843%

825

0.00015%

8,000

0.00143%

3,000

560,832,477

560,831,652

99.99985

%

RES:006

RE-ELECT
MR G CERRONE

560,812,452

99.99643%

12,025

0.00214%

8,000

0.00143%

3,000

560,832,477

560,820,452

99.99786

%

RES:007

RE-ELECT
MR.B DENOYER

560,812,952

99.99673%

10,325

0.00184%

8,000

0.00143%

4,200

560,831,277

560,820,952

99.99816

%

RES:008

APPOINTMENT OF AUDITORS

560,823,652

99.99843%

825

0.00015%

8,000

0.00143%

3,000

560,832,477

560,831,652

99.99985

%

RES:009

DIRECTORS TO ALLOT SHARES

560,822,952

99.99852%

325

0.00006%

8,000

0.00143%

4,200

560,831,277

560,830,952

99.99994

%

RES:010

PRE-EMPTION RIGHTS

560,789,802

99.99260%

33,475

0.00597%

8,000

0.00143%

4,200

560,831,277

560,797,802

99.99403

%


Further information on votes:

As at 17 August 2022, there were 1,415,040,468 ordinary shares in issue. Shareholders are entitled to one vote per ordinary share. Any vote withheld is not a vote in law and so has not been included in the calculation of the proportion of votes for and against any Resolution.

The resolutions were all passed on a poll, with votes cast in accordance with proxy voting instructions submitted to the Company by the relevant deadline, together with those cast at the AGM itself, and will be available on the National Storage Mechanism, https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

The result of poll and proxy voting will also be available on the Company's website, www.okyopharma.com.

Enquiries:

 

 

OKYO Pharma Limited

Gary S. Jacob,
Chief Executive Officer

Tel: +44 (0)20 7495 2379

 

 

 

 

Gabriele Cerrone,
Non-Executive Chairman

 

Optiva Securities Limited (Broker)

Robert Emmet

Tel: +44 (0)20 3981 4173